Eton Pharmaceuticals, Inc. (ETON) stock
ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3089% above fair value
$63.93+2.48 (+4.04%)
Close on Nov 13, 2026Market cap $1.83BP/E 42.1Yield –
Eton Pharmaceuticals statistics
97 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 18, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 42.85
- 2.22
- P/OCF Ratio
- 47.65
- 12.99
Enterprise valuationIndustry
- EV / Sales
- 12.72
- 2.57
- EV / EBIT
- 44.11
- 19.31
- EV / FCF
- 46.96
- 22.27
Share statisticsIndustry
- Shares Change (YoY)
- 16.6%
- 10.8%
- Shares Change (QoQ)
- 1.90%
- 0.50%
- Float
- 27M
- 49M
- Shares Held by Insiders
- 5.57%
- 11.7%
- Shares Held by Institutions
- 74.0%
- 56.4%
Short sellingIndustry
- Short Interest
- 2M
- –
- Short Interest Change
- 2.20%
- -0.80%
- Short % of Float
- 7.36%
- 9.01%
- Short % of Shares Outstanding
- 6.95%
- 6.30%
- Days to Cover
- 5.43
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $70.64
- –
- 52-Week Low
- $14.27
- –
- 20-Day Moving Average
- $54.47
- –
- 50-Day Moving Average
- $55.26
- –
- 200-Day Moving Average
- $37.86
- –
- Average True Range (14)
- $4.23
- –
- Price Change (1 Week)
- 13.2%
- -1.15%
- Price Change (1 Month)
- 24.5%
- -4.87%
- Price Change (3 Months)
- 3.56%
- -21.0%
- Price Change (6 Months)
- 111.3%
- -20.6%
- Price Change (YTD)
- 278.1%
- -23.6%
- Price Change (1 Year)
- 266.2%
- -22.4%
- Price Change (3 Years)
- 1623.2%
- -29.5%
- Price Change (5 Years)
- 1173.5%
- -77.9%
- Average Volume (10 Days)
- 831,784
- –
- Average Volume (20 Days)
- 596,125
- –
- Average Volume (90 Days)
- 596,252
- –
- Relative Volume
- 1.01
- 0.70
- Relative Strength Index (14)
- 61.7
- 43.4
- Volatility (1 Year)
- 75.1%
- 80.1%
- Beta (5 Years)
- 0.88
- 1.07
MarginsIndustry
- Pretax Margin
- 26.3%
- -11.6%
- EBITDA Margin
- 32.4%
- -27.7%
- FCF Margin
- 27.1%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- 90.6%
- -49.9%
- Return on Assets (ROA)
- 38.1%
- -40.6%
- Return on Invested Capital (ROIC)
- 115.0%
- -32.9%
- Return on Capital Employed (ROCE)
- 39.4%
- -37.9%
Financial positionIndustry
- Current Ratio
- 1.79
- 3.30
- Quick Ratio
- 1.52
- 2.39
- Debt / Equity
- 0.27
- 0.49
- Debt / EBITDA
- 0.51
- 3.15
- Debt / FCF
- 0.60
- 4.65
- Net Debt / EBITDA
- -0.71
- 1.97
GrowthIndustry
- Revenue Growth (YoY)
- 100.6%
- 6.82%
- FCF Growth (YoY)
- 81.9%
- 6.85%
- Revenue Growth (3Y CAGR)
- 55.5%
- 2.25%
- Revenue Growth (5Y CAGR)
- 359.6%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 1.08
- 0.40
- Inventory Turnover
- 3.12
- 2.73
- Revenue Per Employee
- $3.21M
- $429.29K
- Profits Per Employee
- $1.13M
- -$689.41K
- Employee Count
- 44
- 74
- WACC
- 9.46%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- $37.06M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $32.56M
- $17.76M
- Net Cash Per Share
- $1.14
- $0.80
- Equity (Book Value)
- $86.92M
- $53.89M
- Book Value Per Share
- $3.04
- $1.50
- Tangible Book Value
- $42.64M
- $27.13M
- Working Capital
- $42.69M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$132.00K
- -$1.00M
- FCF Per Share
- $1.34
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 2.73%
- -21.8%
- FCF Yield
- 2.09%
- -9.44%
Taxes and interestIndustry
- Income Tax
- -$12.80M
- $73.00K
- Effective Tax Rate
- -34.5%
- 20.9%
Scores and fair valueIndustry
- Graham Number
- $10.20
- $19.34
- Graham Upside
- -84.0%
- -46.6%
- Altman Z-Score
- 17.09
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | ETON | S&P 500 | Difference | ETON per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +19.9% | -3.0% | +22.9 pts | ||
| 3 months | +56.7% | -2.8% | +59.5 pts | ||
| Year to date | +278.1% | +11.5% | +266.6 pts | ||
| 1 year | +278.7% | +13.5% | +265.3 pts | ||
| 3 years | +1685.8% | +77.7% | +1608.1 pts | +161.4% | +21.1% |
| 5 years | +1173.5% | +72.6% | +1100.9 pts | +66.3% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
2M ETON shares were sold short on Oct 30, 2026, up 2.2% from the previous report, or 7.36% of the shares available to trade. At recent volumes it would take 5.4 days to buy them back. Over the last 20 sessions, 62.7% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 1,986,167 | +2.2% | 365,610 | 5.4 |
| Oct 15, 2026 | 1,943,339 | +6.0% | 588,430 | 3.3 |
| Sep 30, 2026 | 1,834,090 | +18.9% | 624,706 | 2.9 |
| Sep 15, 2026 | 1,542,982 | +14.5% | 438,622 | 3.5 |
| Aug 31, 2026 | 1,347,971 | -5.6% | 681,758 | 2.0 |
| Aug 14, 2026 | 1,427,797 | +8.7% | 637,002 | 2.2 |
| Jul 31, 2026 | 1,313,359 | +7.1% | 633,128 | 2.1 |
| Jul 15, 2026 | 1,226,286 | -15.4% | 405,195 | 3.0 |
| Jun 30, 2026 | 1,449,499 | +1.7% | 487,785 | 3.0 |
| Jun 15, 2026 | 1,425,624 | +13.0% | 345,181 | 4.1 |
| May 29, 2026 | 1,261,144 | -18.6% | 449,611 | 2.8 |
| May 15, 2026 | 1,548,779 | -5.2% | 478,036 | 3.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?